J&J defends itself in trial over baby powder asbestos claims
(Reuters) – A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays…
FDA chief questions protections on drug rebates, stocks fall
(Reuters) – U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health…
Breast cancer screening failure may have shortened 270 lives in England
LONDON (Reuters) – As many as 270 women’s lives may have been shortened after an IT failure in England’s breast…
Allergan migraine drug succeeds in second late-stage trial
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50…
Ninety-eight now sick from romaine lettuce-linked E. coli: CDC
(Reuters) – Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said…
Fourteen more fall sick from E. coli linked to romaine lettuce: CDC
(Reuters) – Fourteen more sick people from eight U.S. states were added to an investigation of an E. coli outbreak…
FDA cracks down on sales of Juul tobacco products to minors
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it launched a crackdown on the sale of e-cigarettes…
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled…
FDA declines to approve Pfizer’s biosimilar to Roche’s cancer drug
(Reuters) – Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company’s biosimilar…
FDA approves Ultragenyx’s drug for rare form of rickets
(Reuters) – The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical Inc’s treatment for a rare and inherited form…
J&J Baby Powder litigation takes new focus with asbestos claims
NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a…
Theranos lays off most of its remaining workforce: WSJ
(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or…
Kaleo expanding access in U.S. to drug to reverse opioid overdose
(Reuters) – Kaleo Inc, which came under fire last year for the high price of its device to treat opioid…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live…
FDA refuses to review Alkermes’ depression treatment, seeks more trials
(Reuters) – Alkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S.…
Arkansas sues opioid manufacturers for roles in epidemic
(Reuters) – Arkansas’ attorney general on Thursday joined the widening mass of litigation against opioid manufacturers, accusing three drugmakers of…
Biohaven plunges as investors pit migraine data against Allergan’s drug
(Reuters) – Biohaven Pharmaceutical Holding said its treatment for acute migraine cleared two late-stage studies, but investors worried about its…
U.S. judge says opioid settlement roadblocks may prompt trials
(Reuters) – A federal judge pushing for a settlement in lawsuits by state and local governments against drug companies over…